“…Blood is a non-invasive body fluid of choice which is directly under the control of haemopoietic system alterations, and it serves as the main transport medium for many drugs and xenobiotics in the body, also blood components are effortlessly exposed to substantial concentrations of toxic compounds. Circulating blood parameters are a true reflection of metabolomic and process derangements and serve as an excellent prognostic indicator for toxicity, therefore assessment of blood parameters is considered appropriate for drug toxicity risk assessment [ 26 ]. No changes were recorded in blood cell production or haematological parameters after treatment with PHF in this study, indicating that this drug did not adversely affect blood cells.…”